Menu Close

Author: WorkCompAcademy

Early Radiological Studies Ineffective for New Back Pain

New research suggests that older people with a new episode of back pain should not be sent right away for x-rays or other imaging studies. According to the report in Reuters health, they will not be any better off, and they’ will just end up with bigger bills, the researchers say. “We found that they didn’t have worse or better outcomes, and yet they were certainly getting more things done to them downstream,” said Dr. Jeffrey Jarvik, the study’s lead author from the University of Washington in Seattle.

Guidelines (including the ACOEM Guideline) suggest that young people with new back pain should wait a while before getting X-rays, magnetic resonance imaging (MRI) or computed tomography (CT), but the same guidelines make exceptions for older people since there could be more serious underlying conditions. Based on the new results, however, people of every age should not routinely get early imaging studies, the researchers write in JAMA. Jarvik told Reuters Health by phone that older people who get early imaging studies might receive treatments for abnormalities on the tests that ultimately have nothing to do with their back pain.

The researchers looked at data from 5,239 patients age 65 and older who visited their primary care doctor complaining of new back pain and returned for a follow-up visit a year later. Within six weeks of the first visit, 1,523 patients had X-rays, MRIs or CT scans of their backs.

After one year, there was no difference in the disability related to back or leg pain between those who did or did not have early imaging studies, the researchers found. Those who had the X-rays, MRIs or CT scans, however, ended up with medical bills averaging $1,300 higher than for those who didn’t have early imaging studies. Those costs include out-of-pocket payments.

Imaging accounts for most of the $35 billion spent on medical care for lower back pain each year in the U.S., said Manuela Ferreira, associate professor at The George Institute for Global Health and the Institute of Bone and Joint Research of Sydney Medical School at The University of Sydney in Australia. “Adults with sudden back pain do not need to rush to get an X-ray or magnetic resonance imaging (MRI), unless the clinician suspects the patient has a more serious condition, such as fracture or cancer,” Ferreira told Reuters Health by email. “Less than 5 percent of patients with low back pain, however, will fall into this category,” she added. Most of the time, back pain develops from stress and strain on muscles or joints.

“Older adults don’t really need to be treated differently than younger adults,” Jarvik said. Most of the time, the cause of back pain is probably never discovered, he said. “That’s not necessarily a bad thing because most people get better,” he added. “It’s probably not necessary to try and discover exactly why somebody’s back starts hurting, the various investigations you can do often won’t reveal the cause.”

A thorough physical exam and medical history should help doctors distinguish between more benign forms of back strain or a more serious cause, Ferreira said. In the meantime, people can take over-the-counter painkillers and may try physical therapy, which may help overcome a sudden episode of pain, Jarvik said.

Will Tablet Use Be the Next CT Neck Claim?

Tablet use has rocketed. Last year in the US, for example, 42% of under 18’s owned one and more than half of 35-49 year olds used them regularly. This figure seems unlikely to decrease and yet only limited guidance is available on minimizing health risks. Tablet use requires significant head and neck flexion and has implications for potential neck injury to users. In an article in Ergonomics, researchers from Washington State University evaluate the head-neck biomechanics during tablet use, the implications for the neck musculature and future ergonomics recommendations.

Past research has highlighted a link between increased head and neck flexion and pain. Increased activation of neck extensor muscles leave them vulnerable to fatigue and therefore pain. It is not clear though if more risk is associated with type of computer, activity (web browsing, emailing etc.) or if differences in head mass, height and/ or neck muscle strength, often associated with gender, are pivotal.

In the article Gravitational demand on the neck musculature during tablet computer use, Anita N. Vasavada, Derek D. Nevins, Steven M. Monda, Ellis Hughes & David C. Lin, Ergonomics, DOI:10.1080/00140139.2015.1005166, published online 2 February 2015 the authors conducted a study of 33 university students and staff who use regularly used tablets. Users were tested in a variety of usage positions and whilst reading and typing for 2-5 minutes. Radiographs and a biomechanical model were used to assess gravitational demand on the neck and biomechanical ergonomics of the head-neck system during tablet use. The authors hypothesised that tablet use would result in greater gravitational demand than a neutral posture, particularly when used on a lap or flat on a desk. They also speculate that demand will be different for reading vs. typing and finally that gravitational demand will be greater for female users.

The authors discovered that tablet use increases mechanical demand on neck muscles by 3-5 times more than a neutral position.

Using a tablet flat or on lap also had this effect as compared to propped up but whether subject was reading or typing had little effect on level of neck strain; head-neck demand is independent of hand position. A minimal increase in gravitational demand was seen in males but not enough to be significant.

The authors conclude “Our findings are important for developing ergonomics guidelines for tablet computer use because they provide quantitative information about the mechanical requirements of the head-neck musculature, which are directly linked to mechanisms of pain-related problems, under several tablet computer usage conditions.” They urge more research to include further variables such as extent and frequency of use and posture, all of which could be significant in inducing neck pain after tablet use.

UR and IMR – Death by a Thousand Cuts

Recent panel decisions have carved out exceptions to the UR and IMR process to resolve medical disputes. The most significant exception was pronounced in the second en banc case of Dubon v. World Restoration, Inc. (2014) 79 Cal.Comp.Cases 1298. In Dubon II the Appeals Board held that any “determination of medical necessity” is to be made by the WCAB following an untimely UR, and is to be “based on substantial medical evidence consistent with Labor Code section 4604.5.”

However, the WCAB in Dubon confirmed the mechanics of what is required to show “substantial evidence” supporting a request for medical care. Quoting from Sandhagen: the WCAB in Dubon said “The Legislature amended section 3202.5 to underscore that all parties, including injured workers, must meet the evidentiary burden of proof on all issues by a preponderance of the evidence. (Stats. 2004, ch. 34, § 9.) Accordingly, notwithstanding whatever an employer does (or does not do), an injured employee must still prove that the sought treatment is medically reasonable and necessary. That means demonstrating that the treatment request is consistent with the uniform guidelines (§ 4600, subd. (b)) or, alternatively, rebutting the application of the guidelines with a preponderance of scientific medical evidence (§ 4604.5).” (Sandhagen, supra, 44 Cal.4th at p. 242 [bolding added].)

Unfortunately, the requirement for a showing that a request for treatment meets some type of a “uniform guideline” was ignored in the recent panel decision of Jared Carnes v Auto Zone.

In an Expedited Hearing, the parties stipulated that the UR was not timely. The WCJ therefore obtained jurisdiction over whether or not to award the treatment requested by Dr. Eichbaum. A Findings and Order, ruled that applicant had presented substantial evidence of need for medical treatment consisting of a sleep number bed that cost $5,325.86. The WCAB denied reconsideration in the split panel decision.

Dr. Eichbaum made a Request for Authorization setting forth that applicant was scheduled for a major lumbar surgical procedure. He has difficulty with sleeping and his bed is over fifteen years old. He has a very poor mattress. Dr. Eichbaum recommends a new mattress better suited for him and his condition to alleviate his pain and allow him to get rest. In his next letter Dr. Eichbaum said that applicant was scheduled for a lumbar decompression and fusion. In order to optimize his recovery, he’ll need an appropriate bed to sleep on after the surgery. Dr. Eichbaum states that applicant has an inadequate bed and this would definitely be a problem following his surgery.Dr. Eichbaum specifically indicates that a “Sleep Number 18” mattress would be ideal after the surgery and would maximize his ability to recover.

What was missing from the record was any reference to any “uniform guideline” by the treating physician in his reporting, or any other medical professional that that supported an order for this bed. The decision is therefore a step back from the limits specified in Dubon and Sandhagen. The digression from exiting law that requires evidence from a “uniform guideline” did not go unnoticed by Commissioner Zalewski in the dissenting opinion.

The dissent goes on to note that an employer is obligated to provide medical treatment ”that is reasonably required to cure or relieve the injured worker from the effects of his or her injury … ” (Lab. Code, § 4600, emphasis added.) Through its enactment of recent statutes, the Legislature has shown that a dispute over whether a proposed medical treatment is reasonably required is to be determined by the use of evidence-based standards and medical opinion. (See Lab. Code, § 5307.27 [which provides for the development of a medical treatment utilization schedule (MTUS) that “shall incorporate the evidence-based, peer reviewed, nationally recognized standards of care”] and § 4610.5(c)(2) [defining “medically necessary” and “medical necessity” based upon a hierarchy of standards as follows: “A) The guidelines adopted by the administrative director pursuant to Section 5307.27. (B) Peer-reviewed scientific and medical evidence regarding the effectiveness of the disputed service. (C) Nationally recognized professional standards. (D) Expert opinion. (E) Generally accepted standards of medical practice. (F) Treatments that are likely to provide a benefit to a patient for conditions for which other treatments are not clinically efficacious.”]; cf. Lab. Code, §§ 4604.5 [MTUS are presumed to be correct on the issue of extent and scope of medical treatment], 46 I 0 [UR], 4610.5 and 4610.6 [independent medical review].)”

Commissioner Zelewski points out that none the evidence in this case meets this standard, and thus the Finding is not supported by substantial evidence. The majority consisting of Commissioners Frank Brass and Marguerite Sweeny seemed to believe that this standard was met, without explanation except to say that “For the reasons stated by the WCJ in his Report, which is adopted and incorporated by this reference, the December 23, 2014 decision is affirmed and defendant’s petition for reconsideration is denied.”

The mandates of Sandhagen and Dubon have thus been eroded – without explanation by the majority,- and are in the process of death by a thousand small cuts.

Medical Fraud Setting Records in 2015

In 2014, the federal government recovered nearly $5.7 billion in fraud cases, up $1.9 billion from the prior fiscal year. Of that amount, $2.3 billion was tied to fraud against the federal government. Already, 2015 has seen a host of major fraud news involving dozens of individuals and amounting to millions in abuse, often related to Medicare fraud.

$100 Million: Thirty-seven people, including 24 doctors, pleaded guilty to a massive healthcare bribery scheme resulting in more than $100 million in payments from Medicare and various private insurance companies to Biodiagnostic Laboratory Services in New Jersey. On March 3, Michael J. Zarrelli, 48, of Berkeley Heights, New Jersey pleaded guilty to bribing a doctor in exchange for test referrals.

$75 Million: Community Health Systems and three of its hospitals in New Mexico in February agreed to pay a $75 million settlement to the federal government over a whistleblower suit that claimed it illegally donated money between 2000 and 2011 to New Mexico counties in return for higher Medicaid payments to cover the costs of indigent care. The activity was uncovered by whistleblower Robert Baker, a former revenue manager at Community Health Systems Professional Services Corp.

$30 Million: Operators of a Louisiana home care company, Priority Care at Home, as well as 20 other accomplices were indicted in March for their alleged role in a $30 million Medicare fraud scheme. The defendants allegedly hired “house doctors” to sign orders and plans of care for Medicare beneficiaries who had no legitimate medical necessity for home health services.

$14 Million: Jonathan Wade Dunning, a former CEO of two nonprofit health clinics in Alabama, was arrested in February on 112 counts related to alleged conspiracy, fraud and money-laundering of cash meant for the poor and homeless. The charges allege Dunning, as CEO and in other positions, participated in conspiracy and executed schemes to defraud Birmingham Health Care, Central Alabama Comprehensive Health and others of “substantial resources,” according to the indictment.

$7.9 Million: Pharmaceutical giant AstraZeneca in February agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme regarding its drug Nexium. The complaint said AstraZeneca paid Medco Health Solutions, a pharmacy benefit manager, in exchange for Medco maintaining Nexium’s “sole and exclusive” status on certain Medco formularies and through other marketing activities.

$6.9 Million: Orelvis Olivera, a 45-year-old owner of Acclaim Home Health Care in Miami, in February admitted to running a $6.9 million Medicare fraud in which he and his conspirators billed the government for expensive therapies that patients did not need.

$3.5 Million:The New York-based Catholic Health Care System, an operator of skilled nursing facilities, agreed in March to pay $3.5 million to settle allegations that it inflated Medicare claims for rehabilitation therapy.

$1.6 Million: Vivian Yusuf, 44, the former owner of the Houston-area Ivy Health Care Supply company in February was sentenced to 7 years federal prison and ordered to pay $1.6 million in restitution on a conviction of conspiracy to commit healthcare fraud. From June 2007 to May 2009, Yusuf and co-conspirators improperly acquired Medicare patient information to submit false claims to Medicare totaling more than $3.4 million.

$1.1 Million: A Texas man impersonating an MRI salesman working with Cerner Corp. convinced employees of a Dallas hospital to wire him more than $1 million using an elaborate network of fake correspondence and several co-conspiratorsi. Albert Davis, 54, of Richardson, Texas, was charged with wire fraud after employees of Dallas Medical Center and Prime Health Care — which acquired the hospital during the course of the scheme — transmitted two wire payments totaling $1.1 million to the conspirators’ bank account to purchase the MRI.

Is Comp Fraud Grant Funding Model a Solution for Underground Economy Fight?

The California Little Hoover Commission, is an independent state agency charged with recommending ways to improve the efficiency and effectiveness of state programs. The Commission’s recommendations are submitted to the Governor and the Legislature for their consideration and action. By statute, the Commission is a bipartisan board composed of five public members appointed by the governor, four public members appointed by the Legislature, two senators and two assemblymembers.

The Commission said in the 140 page report, that California businesses are losing ground to unscrupulous competitors who break the rules to gain an unfair advantage,in a report calling on the Governor and Legislature to more effectively fight the state’s underground economy. The Commission found the underground economy is growing and thriving in part because of insufficient resources for enforcement. The Commission learned that many cheaters break the rules because getting caught is unlikely. If they are caught, few are charged in court. When found guilty, the profits from cheating often outweigh the fines and penalties. More, there is an abysmal record of collecting restitution. The state loses an estimated $8.5 billion or more annually in tax revenue, yet efforts to combat the underground economy are disjointed and under-resourced, the Commission found. It reported that the state’s bureaucratic disorganization and neglect provide significant incentives to cheat, making the rewards of participating in the underground economy outweigh the risks.

The Commission found that existing laws can be so confusing and inconsistent that even business owners who try to comply sometimes later learn they have broken rules. Recommended improvements include defining independent contractor in statute, bolstering asset seizure laws, and generally refining laws to improve clarity and to ensure rewards don’t outweigh risks.

The Commission also recommends replicating the current workers’ compensation fraud grant funding model to other high-fraud areas, enabling local district attorneys to increase their role in tackling the underground economy. Many stakeholders told the Commission that the workers’ compensation grant model, financed by premiums paid by California employers for fraud investigations and prosecutions, is an effective funding model. Nearly $59 million has been allocated for the FY 2015-16 grant cycle. A worker’s compensation manager of a Fortune 100 company and member of the Fraud Assessment Commission, which determines how much grant funding will be available for the program, told Commission staff that good oversight is what makes the grant process effective. “The Fraud Assessment Commission pushes and pushes and pushes for counties to do better. We constantly tell them that they have to do better to get the money. And it works,” he said. “If similar programs are established, you should create a similar mechanism that requires proven performance for funding.”

Counties funded by the grant dedicate prosecutors to investigating workers’ compensation fraud. “I have no problem finding prosecutors for workers’ compensation cases, because of the grant,” the EDD Chief of Investigations told the Commission.Many district attorney offices have opened workers’ compensation fraud sections, in part because of the grant. Representatives from the Orange County District Attorney’s Office said the grant program allowed them to hire fraud specialists. “These cases can take years sometimes to get up to speed. The grant funding allows someone to build an expertise in fraud.”

Prosecutors investigating workers’ compensation fraud cases frequently uncover additional unlawful activity. San Bernardino Deputy District Attorney David Simon told Commission staff: “Workers’ compensation fraud is just one spoke in a wheel of a wide variety of illegal conduct that we refer to as unfair business practices. This is what the Business and Professions Code defines as practices that unfairly advantage one business that disadvantage another business in the free market. We find that businesses without workers’ compensation are often unlicensed to do contracting, engaging in cash-pay transactions and income tax evasion, not paying overtime or engaging in theft of labor. They’re all related and a legitimate business person cannot possibly compete against the bid of these companies.”

The Report concludes “Because of the effectiveness of the workers’ compensation grant program, stakeholders suggested that it could be expanded and replicated in other high-fraud areas, including dedicated funding for complex cases.”

FDA Modifies Approval Process to Limit Superbug Infection

The U.S. Food and Drug Administration announced new actions to enhance the safety of reusable medical devices and address the possible spread of infectious agents between uses. A key change is that when manufacturers submit instructions for disinfecting the devices between uses, the Food and Drug Administration will not take the company’s word that the instructions work, but will demand proof. In the past, the agency essentially took manufacturers at their word when they claimed a procedure worked; now they will have to submit data proving so “with a high degree of assurance,” the agency said. The new recommendations are outlined in a final industry guidance aimed at helping device manufacturers develop safer reusable devices, especially those devices that pose a greater risk of infection.

The FDA issued a draft guidance discussing the reprocessing of reusable medical devices in 2011, and considered almost 500 comments before issuing the final guidance. The final guidance provides more clarity about testing protocols and what data should be submitted to the agency for a premarket submission, such as the data FDA needs to evaluate substantial equivalence for a 510(k) premarket submission. Manufacturers seeking to bring to market certain reusable devices, such as duodenoscopes, bronchoscopes and endoscopes, should submit to the FDA for review their data validating the effectiveness of their reprocessing methods and instructions.

FDA’s final guidance document, titled “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” includes recommendations medical device manufacturers should follow pre-market and post-market for the safe and effective use of reprocessed devices. A device manufacturer’s reprocessing instructions are critical to protect patients against the spread of infections. As part of its regulatory review for reusable medical devices, the FDA reviews the manufacturer’s reprocessing instructions to determine whether they are appropriate and able to be understood and followed by end users. The guidance lists six criteria that should be addressed in the instructions for use with every reusable device to ensure users understand and correctly follow the reprocessing instructions.

Separately, the FDA also announced in the Federal Register that the agency’s Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee will hold a public meeting on May 14 and 15, 2015 to discuss recent reports and epidemiologic investigations of transmission of infections associated with the use of duodenoscopes in endoscopic retrograde cholangiopancreatography (ERCP) procedures in hospitals in the United States.

The FDA action followed reports last month that hundreds of patients may have been exposed to pathogens, including antibiotic-resistant “superbugs,” after flexible tubes called duodenoscopes were not properly disinfected between patients. Two patients at the University of California-Los Angeles died. The new recommendations apply, however, not only to duodenoscopes but to most medical devices intended for repeated use, including bronchoscopes and endoscopes.

To deal with the thousands of devices already in use, whose disinfection protocols were not subjected to rigorous validation, the U.S. Centers for Disease Control and Prevention released instructions for reducing the risk of transmitting infections. The protocol calls for swabbing the device after it has supposedly been disinfected and seeing if any microbes grow into detectable colonies, much as doctors take throat swabs to determine if a patient has a strep infection, before the device is used again. The duodenoscopes at the center of the recent superbug outbreaks are made by Olympus Corp, Fujifilm Holdings Corp, and Pentax.

As far back as 2009, the FDA believed that transmission of infection by duodenoscopes occurred when hospitals did not properly follow manufacturers’ instructions for “reprocessing,” or disinfecting, the devices between use. Only recently, the agency said, did it conclude that such transmission can occur even when the instructions are followed to the letter, an indication of how difficult it is to clean the complex equipment.

The FDA does not, however, “have the authority to require manufacturers to change their (device’s) design” even if it prevents disinfection, Dr. William Maisel, FDA’s deputy center director for science, told reporters.

CWCI – WCIRB Joint Study Confirms SB863 ASC Cost Savings

In recent years, the increasing cost of treatment at ambulatory surgery centers has been one factor in the escalation of California workers’ compensation medical costs. In 2012, state lawmakers sought to address these escalating costs by including provisions in SB 863 that, among other things, reduced the maximum facility fees for services performed in ASCs to 80 percent of the fee paid by Medicare for the use of hospital outpatient surgery departments. The WCIRB initially projected that this change in the fee schedule would reduce ASC payments by 25 percent. This new WCIRB CIRB joint study is a follow-up to the authors’ initial February 2014 study that measured the extent to which the change in ASC reimbursements achieved its intended goal of reducing these costs. It includes an entire year of additional data, encompassing episodes from January 2012 through June 2014.

Prior to 2004, California workers’ compensation outpatient surgery facility fees were not subject to a fee schedule, and payments varied widely as payers negotiated or paid usual and customary fees. In the absence of a fee schedule, California workers’ compensation paid significantly more than federal health care programs such as Medicare for comparable services, as was noted in a 2002 study by Kominsky and Gardner.

In 2003, California lawmakers amended Labor Code §5307.1(c)(1) in SB 228 to require the Division of Workers’ Compensation (DWC) to promulgate a fee schedule that utilizes the Medicare payment rules for the use of outpatient surgery rooms and emergency rooms. Under Medicare, each Current Procedural Terminology (CPT) code for a specific outpatient surgical procedure is classified into an Ambulatory Procedure Classification (APC). The final fee is calculated using a formula rather than a prescribed dollar amount. Under the fee schedule, which took effect for services on or after June 15, 2004, maximum facility fees could not exceed 120 percent of the Medicare fee. The adoption of the outpatient facility fee schedule had an immediate effect on costs. CWCI research from 2005 compared pre and post SB 228 payments for 239 distinct outpatient procedures performed in ASCs and found that after adjusting for medical inflation and changes in the mix of medical procedures, average outpatient surgery facility fee payments fell 38.9 percent following the adoption of the Outpatient Surgery Facility Fee Schedule in 2004.

By 2012, however, several years of escalating workers’ compensation medical costs and a growing desire to increase injured workers’ permanent disability benefits led state lawmakers to revisit the issue of ASC fees as one cost-saving component of a legislative reform deal (SB 863) hammered out by representatives of labor, employers and the Brown Administration.The final version of that bill called for the DWC to modify the Outpatient Facility Fee Schedule so that maximum facility fees for services performed in ASCs were reduced from 120 percent to 80 percent of the Medicare fee for those services, though hospital-based outpatient facility maximum fees were kept at 120 percent of the Medicare rate.

As found in the prior study, this update on the effects of SB 863 finds that the reduction in payments has been slightly better than the initial predictions, with a 27 percent decrease in payments per episode and a 29 percent decrease in the payments per procedure from the pre-reform to the post- reform period. There was no evidence of significant changes in service mix or intensity or shifts away from the ASC to the hospital setting. The study concludes by saying “These results are similar to the 2014 findings using the identical measures and show that thus far, the change in the ASC Fee Schedule has achieved its intended objective of reducing one aspect of workers’ compensation medical costs.

Orange County Pair Convicted of $71 Million Surgical Center Fraud

A federal jury has convicted two Southern California residents in connection with a scheme to defraud union and private health insurance programs by submitting bills for more than $71 million and receiving over $50 million in payments for medically unnecessary procedures performed on insurance beneficiaries who received free or discounted cosmetic surgeries. A large number of the fraudulent claims were submitted to the International Longshore and Warehouse Union and Operating Engineers Union health insurance plans. Other victim insurers included Aetna and Anthem.

The two defendants found guilty are Theresa Fisher, 45, of Tustin, who was found guilty of five counts of mail fraud; and Lindsay Hardgraves, 30, of San Pedro, who was found guilty of two counts of mail fraud.

The evidence presented during a six-day trial showed that members of the scheme lured insured “patients” to a surgery center in Orange with promises that they could use their union or PPO health insurance plans to pay for cosmetic surgeries, which are generally not covered by insurance. The surgery center was known at various times as Princess Cosmetic Surgery, Vista Surgical Center, and Empire Surgical Center.

Marketers such as Hardgraves referred “patients” to the surgery center, where they were told they could receive free or discounted cosmetic surgeries if they underwent multiple, medically unnecessary procedures that would be billed to their union or PPO health care benefit program. Fisher was a consultant at the surgery center who scheduled procedures after telling the “patients” about the free cosmetic procedures they could receive and coaching them to fabricate or exaggerate symptoms so that their medical procedures would be covered by their insurance.

The unnecessary procedures typically performed on the “patients” were endoscopies (usually sophagogastroduodenoscopies, or EGDs), colonoscopies and cystoscopies. Once the health care benefit program paid the claims, the patients were given free or discounted cosmetic surgeries, including tummy tucks, breast augmentations and liposuction. In some cases, the surgery center simply billed cosmetic procedures (such as tummy tucks) as if they were medically necessary procedures (such as hernia surgeries).

Fisher and Hardgraves are scheduled to be sentenced on May 29. A third defendant in this case – Vi Nguyen, 31, of Placentia, another consultant at the surgery center – pleaded guilty in January to four counts of mail fraud and faces sentencing before Judge Staton on July 10. At sentencing, each defendant faces a statutory maximum sentence of 20 years in federal prison for each count of mail fraud.

Orange County Insurance Agent Sentenced to Seven Years

Jacob Richard Bonzer, 28, formerly of Lake Forest, Calif. was arrested last August in Chicago by a U.S. Marshals Task Force on 96 felony counts including grand theft, forgery and denial of benefits. He pleaded guilty and was sentenced to seven years in prison last Friday for selling fraudulent insurance polices in Orange County to fund a lavish lifestyle.

Between 2009 to 2013, Bonzer, collected more than $900,000 in commissions and premium payments for the fake polices, and created fake insurance companies to defraud customers, a statement from the Orange County District Attorney said.

Before being sentenced, Bonzer pleaded guilty to 49 counts of grand theft, one felony count of forging a California Department of Insurance Examination report, transacting insurance business without a certificate of authority, 45 felony counts of insurance fraud, with sentencing enhancements for aggravated white-collar crime totaling more than $500,000 and taking more than $200,000. He was ordered to pay $918,300 to his victims. Bonzer used the money to pay for fine dining, travel, wine club memberships and to rent luxury high-rise apartments.

Between 2009 to 2010, Bonzer worked at a Farmers Insurance Group office in Brea, before being fired after failing the company’s career program. The Department of Insurance received a complaint alleging Bonzer submitted 128 fraudulent homeowners insurance applications containing bogus information using nonexistent policyholders for real properties, causing valid policies to be issued for phantom homeowners in escrow. Bonzer allegedly received $46,000 in advanced commissions from the insurance company that expected to collect premiums when the properties closed escrow. Since the applicants were bogus, the insurer never received premium payments and Bonzer was eventually fired.

In 2011, he continued his criminal activities and created a fake company and, with another insurance agent to whom he lied, created 800 more homeowner polices that listed fake names. The fake company was called GW Mutual Risk Retention Group, LLC, which was registered in Florida. GW Mutual is not licensed to write insurance in California though Bonzer sold workers’ comp and commercial insurance policies through his agency, Bonzer Insurance Brokerage, located in Orange County.

Bonzer collected roughly $280,000 in premium from 58 California businesses that believed they were purchasing valid coverage.The other agent paid back his half of the $573,242 in commissions. When questioned by a customer about his ability to sell insurance in California, Bonzer provided him with a fake document from the state department of insurance.

Bonzer orchestrated these elaborate scams by using multiple post office boxes, virtual assistants, business entities, office spaces, email accounts, website domains and bank accounts.

National Prescription Drug Spending Increased 13%

The nation’s largest pharmacy benefits manager says prescription drugs spending rose 13 percent last year, the largest annual increase since 2003. Express Scripts says the gains were fueled by pricey specialty drugs that accounted for about 31 cents of every dollar spent on prescriptions even though they represented only 1 percent of all U.S. prescriptions filled.

New hepatitis C therapies with high price tags and the exploitation of loopholes for compounded medications drove a 13.1% increase in U.S. drug spending in 2014 – a rate not seen in more than a decade. The report says that these findings “demonstrate the need for plans to take decisive action and more closely manage the pharmacy benefit to ensure all patients are able to achieve the best possible health outcomes at a price our country can afford.”

Inflammatory conditions, multiple sclerosis and cancer remained the top three specialty therapy classes for the fifth consecutive year, collectively contributing to 55.9% of the spend for all specialty medications billed through the pharmacy benefit in 2014.

Spending on traditional medications continues to rise as a result of compounded drugs, which emerged in the top 10 traditional therapy classes for the first time and accounted for 35% of the increase in spending. However, Express Scripts expects spend on compounded medications to decline sharply in 2015 due to widespread adoption of our compound utilization management solution. Express Scripts’ compound management solution, implemented in mid-2014, will save its clients more than $1.9 billion in 2015 that would have otherwise been wasted on compounded medications that do not provide a proven clinical benefit.

Drugmaker consolidation and drug shortages also led to increases in traditional drug trend, which rose to 6.4% in 2014. Half of the top 10 therapy classes experienced negative trend in 2014 due to generics. While it expects that trend to persist for the next two years, some categories will face challenges from continued drugmaker consolidation, which can lead to price increases from drug shortages and decreased competition.